Co-administration of apocynin with lipoic acid enhances neuroprotection in a rat model of ischemia/reperfusion

Neuroscience Letters

Volumn 507, Issue 1, 2012, Pages 43-46

  Connell, Barry J ^a   Saleh, Tarek M ^a  

^a UNIVERSITY OF PRINCE EDWARD ISLAND   (Canada)

Author keywords

Antioxidant; Ischemia reperfusion; NADPH oxidase inhibitor; Neuroprotection; Stroke

Indexed keywords

APOCYNIN; THIOCTIC ACID;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; DRUG EFFECT; DRUG POTENTIATION; MALE; MIDDLE CEREBRAL ARTERY; MIDDLE CEREBRAL ARTERY OCCLUSION; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT; STROKE;

ACETOPHENONES; ANIMALS; BRAIN; BRAIN ISCHEMIA; DRUG COMBINATIONS; HUMANS; MALE; NEUROPROTECTIVE AGENTS; RATS; RATS, SPRAGUE-DAWLEY; REPERFUSION INJURY; THIOCTIC ACID; TREATMENT OUTCOME;

EID: 84855200406     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2011.11.047     Document Type: Article

References (32)

1. Babu G.N., Kumar A., Singh R.L. Chronic pretreatment with acetyl-l-carnitine and ±dl-α-lipoic acid protects against acute glutamate-induced neurotoxicity in rat brain by altering mitochondrial function. Neurotox. Res. 2010, 10.1007/s12640-010-9165-3.
2. Bano M., Bhatt D.K. Ameliorative effect of a combination of vitamin E, vitamin C, α-lipoic acid and stilbene resveratrol on lindane induced toxicity in mice olfactory lobe and cerebrum. Ind. J. Exp. Biol. 2010, 48:150-158.
3. Bedard K., Krause K.H. The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiol. Rev. 2007, 87:245-313.
4. Biewenga G.P., Haenen G.R.M., Bast A. The pharmacology of the antioxidant lipoic acid. Gen. Pharm. 1997, 29:315-331.
5. Cao X.H., Phillis J.W. The free radical scavenger α-lipoic acid protects against cerebral ischemia-reperfusion injury in gerbils. Free Radic. Res. 1995, 23:365-370.
6. Castor L.R.G., Locatelli K.A., Ximenes V.F. Pro-oxidant activity of apocynin radical. Free Radic. Biol. Med. 2010, 48:1636-1643.
7. Chan P.H. Reactive oxygen radicals in signaling and damage in the ischemic brain. J. Cereb. Blood Flow Metab. 2001, 21:2-14.
8. Chen H., Song Y.S., Chan P.H. Inhibition of NADPH oxidase is neuroprotective after ischemia reperfusion. J. Cereb. Blood Flow Metab. 2009, 29:1262-1272.
9. Clark W.M., Rinker L.G., Lessov N.S., Lowery S.L., Cipolla M.J. Efficacy of antioxidant therapies in transient focal ischemia in mice. Stroke 2001, 32:1000-1004.
10. Connell B.J., Saleh M., Khan B.V., Saleh T.M. Apocynin may limit total cell death following cerebral ischemia and reperfusion by enhancing apoptosis. Food Chem. Toxicol. 2011, 49:3063-3069.
11. Connell B.J., Saleh M., Khan B.V., Saleh T.M. Lipoic acid protects against reperfusion injury in the early stages of cerebral ischemia. Brain Res. 2011, 1375:128-136.
12. Connell B.J., Saleh T.M. A novel rodent model of reperfusion injury following occlusion of the middle cerebral artery. J. Neurosci. Methods 2010, 190:28-33.
13. Garcia-Estrada J., Gonzalez-Perez O., Gonzalez-Castaneda R.E., Martinez-Contreras A., Luquin S., Garzon de la Mora P., Navarro-Ruiz A. An alpha-lipoic acid-vitamin E mixture reduces post-embolism lipid peroxidation, cerebral infarction, and neurological deficit in rats. Neurosci. Res. 2003, 47:219-224.
14. Ginsberg M.D. Current status of neuroprotection for cerebral ischemia: synoptic overview. Stroke 2008, 40:S111-S114.
15. Gonzalez-Perez O., Gonzalez-Castaneda R.E., Heurta M., Luquin S., Gomez-Pinedo U., Sanchez-Almaraz E., Navarro-Ruiz A., Garcia-Estrada J. Beneficial effects of α-lipoic acid plus vitamin E on neurological deficit, reactive gliosis and neuronal remodeling in the penumbra of the ischemic rat brain. Neurosci. Lett. 2002, 321:100-104.
16. Green A.R. Pharmacological approaches o acute ischemic stroke: reperfusion certainly, neuroprotection possibly. Br. J. Pharmacol. 2008, 153:S325-S338.
17. Jackman K.A., Miller A.A., DeSilva T.M., Crack P.J., Drummond G.R., Sobey C.G. Reduction of cerebral infarct volume by apocynin requires pretreatment and is absent in Nox2-deficient mice. Br. J. Pharmacol. 2009, 156:680-688.
18. Kelly K.A., Li X., Tan Z., Van Gilder R.L., Rosen C.L., Huber J.D. NOX2 inhibition with apocynin worsens stroke outcome in aged rats. Brain Res. 2009, 1292:165-172.
19. Mukherjee R., Banerjee S., Joshi N., Singh P.K., Baxi D., Ramachandran A.V. A combination of melatonin and alpha lipoic acid has greater cardioprotective effect than either of them singly against cadmium-induced oxidative damage. Cardiovasc. Toxicol. 2011, 11:78-88.
20. Panigrahi M., Sadguna Y., Shivakumar B.R., Kolluri S.V.R., Roy S., Packer L., Ravindranath V. α-Lipoic acid protects against reperfusion injury following cerebral ischemia. Brain Res. 1996, 717:184-188.
21. Richard M.J.P., Connell B.J., Khan B.V., Saleh T.M. Cellular mechanisms by which lipoic acid confers protection during the early stages of cerebral ischemia: a possible role for calcium. Neurosci. Res. 2011, 69:299-307.
22. Riganti C., Costamagna C., Doublier S., Miraglia E., Polimeni M., Bosia A., Ghigo D. The NADPH oxidase inhibitor apocynin induces nitric oxide synthesis via oxidative stress. Toxicol. Appl. Pharmacol. 2008, 228:277-285.
23. Riganti C., Costamagna C., Bosia A., Ghigo D. The NADPH oxidase inhibitor apocynin (acetovanillone) induces oxidative stress. Toxicol. Appl. Pharm. 2006, 212:179-187.
24. Shotton H.R., Broadbent S., Lincoln J. Prevention and partial reversal of diabetes-induced changes in enteric nerves of the rat ileum by combined treatment with α-lipoic acid and evening primrose oil. Auton. Neurosci.: Basic Clin. 2004, 111:57-65.
25. Sola S., Mir M.Q.S., Cheema F.A., Khan-Merchant N., Menon R.G., Parthasarathy S., Khan B.V. Irbesartan and lipoic acid improve endothelial function and reduce markers of inflammation in the metabolic syndrome. Results of the Irbesartan and lipoic acid in endothelial dysfunction (ISLAND) study. Circulation 2005, 111:242-248.
26. Stefanska J., Pawliczak R. Apocynin: molecular aptitudes. Mediators Inflamm. 2008, 1-10. DOI:1155/2008/106507.
27. Sun A.Y., Wang Q., Simonyi A., Sun G.Y. Botanical phenolics and brain health. Neuromol. Med. 2008, 10:259-274.
28. Tang X.N., Cairns B., Cairns N., Yenari M.A. Apocynin improves outcome in experimental stroke with a narrow dose range. Neuroscience 2008, 154:556-562.
29. Tang L.L., Ye K., Yang X.F., Zheng J.S. Apocynin attenuates cerebral infarction after transient focal ischaemia in rats. J. Int. Med. Res. 2007, 35:517-522.
30. Vejrazka M., Micek R., Stipek S. Apocynin inhibits NADPH oxidase in phagocytes but stimulates ROS production in non-phagocytic cells. Biochem. Biophys. Acta 2005, 722:143-147.
31. Wolz P., Krieglstein J. Neuroprotective effects of α-lipoic acid and its enantiomers demonstrated in rodent models of focal cerebral ischemia. Neuropharmacology 1996, 35:369-375.
32. Zhao H., Mayhan W.G., Arrick D.M., Xiong W., Sun H. Alcohol-induced exacerbation of ischemic brain injury: role of NAD(P)H oxidase. Alcohol. Clin. Exp. Res. 2010, 14:1-8.